BE891393A - Esthers d'hydroxymethylpyrazines substituees leur preparation et leur utilisation therapeutique - Google Patents

Esthers d'hydroxymethylpyrazines substituees leur preparation et leur utilisation therapeutique

Info

Publication number
BE891393A
BE891393A BE0/206772A BE206772A BE891393A BE 891393 A BE891393 A BE 891393A BE 0/206772 A BE0/206772 A BE 0/206772A BE 206772 A BE206772 A BE 206772A BE 891393 A BE891393 A BE 891393A
Authority
BE
Belgium
Prior art keywords
hydroxymethylpyrazine
esthers
substituted
preparation
therapeutic use
Prior art date
Application number
BE0/206772A
Other languages
English (en)
Inventor
P Cozzi
A Pillan
L Bertone
P P Lovisolo
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE891393A publication Critical patent/BE891393A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/206772A 1980-12-09 1981-12-08 Esthers d'hydroxymethylpyrazines substituees leur preparation et leur utilisation therapeutique BE891393A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8039357 1980-12-09

Publications (1)

Publication Number Publication Date
BE891393A true BE891393A (fr) 1982-06-08

Family

ID=10517843

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206772A BE891393A (fr) 1980-12-09 1981-12-08 Esthers d'hydroxymethylpyrazines substituees leur preparation et leur utilisation therapeutique

Country Status (22)

Country Link
US (2) US4766214A (fr)
JP (1) JPS57122069A (fr)
AT (1) AT382369B (fr)
AU (1) AU541143B2 (fr)
BE (1) BE891393A (fr)
CA (1) CA1180711A (fr)
CH (1) CH650256B (fr)
DE (1) DE3146867A1 (fr)
DK (1) DK149451C (fr)
FI (1) FI73210C (fr)
FR (1) FR2495615A1 (fr)
GB (1) GB2091725B (fr)
HK (1) HK79186A (fr)
IE (1) IE51729B1 (fr)
IL (1) IL64267A (fr)
IT (1) IT1139861B (fr)
MY (1) MY8600399A (fr)
NL (1) NL8105546A (fr)
SE (1) SE456579B (fr)
SU (1) SU1176837A3 (fr)
YU (2) YU42742B (fr)
ZA (1) ZA818446B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2621878B2 (ja) * 1987-09-22 1997-06-18 保土谷化学工業株式会社 ジシアノピラジン誘導体
CA2209465C (fr) * 1996-07-11 2008-04-29 Lonza Ag Methode de preparation de 3-alcoxy-5-alkylpyrazin-2-amines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3544682A (en) * 1968-03-18 1970-12-01 Lilly Co Eli Fungicidal control method employing substituted pyrazines
US3901886A (en) * 1968-11-08 1975-08-26 Mcneilab Inc Certain derivatives of pyrazinylmalonates
US3928347A (en) * 1968-11-08 1975-12-23 Mcneilab Inc Pyrazinylmalonic acid esters and salts and pyrazinylacetic acids, esters and salts
US4051245A (en) * 1972-04-28 1977-09-27 Carlo Erba, S.P.A. Pyrazine 4-oxide derivatives and process for their preparation
US4002750A (en) * 1972-04-28 1977-01-11 Carlo Erba S.P.A. Pyrazine 4-oxide derivatives and process for their preparation
US3952026A (en) * 1974-06-24 1976-04-20 Firmenich & Cie 5-Methyl-furfuryl furfuryl ether
IT1094287B (it) * 1978-03-23 1985-07-26 Erba Carlo Spa Derivati della 2-idrossimetil-pirazina aventi attivita' ipolipemizzante
US4406901A (en) * 1980-02-06 1983-09-27 Farmitalia Carlo Erba S.P.A. Ethers of substituted hydroxymethylpyrazines

Also Published As

Publication number Publication date
YU42868B (en) 1988-12-31
AU7792181A (en) 1982-06-17
FI73210B (fi) 1987-05-29
US4766214A (en) 1988-08-23
IL64267A0 (en) 1982-02-28
SE456579B (sv) 1988-10-17
IT1139861B (it) 1986-09-24
IL64267A (en) 1985-08-30
IE51729B1 (en) 1987-03-04
DE3146867C2 (fr) 1990-07-26
YU141483A (en) 1984-02-29
CA1180711A (fr) 1985-01-08
AU541143B2 (en) 1984-12-20
CH650256B (fr) 1985-07-15
MY8600399A (en) 1986-12-31
SE8107351L (sv) 1982-06-10
AT382369B (de) 1987-02-25
ZA818446B (en) 1982-10-27
GB2091725A (en) 1982-08-04
DK149451B (da) 1986-06-16
US4801711A (en) 1989-01-31
IE812876L (en) 1982-06-09
FI813869L (fi) 1982-06-10
NL8105546A (nl) 1982-07-01
GB2091725B (en) 1984-11-14
YU42742B (en) 1988-12-31
FI73210C (fi) 1987-09-10
FR2495615A1 (fr) 1982-06-11
IT8125321A0 (it) 1981-11-27
JPH0354100B2 (fr) 1991-08-19
DK149451C (da) 1987-03-23
DK542681A (da) 1982-06-10
ATA516581A (de) 1986-07-15
YU272481A (en) 1984-02-29
HK79186A (en) 1986-10-31
JPS57122069A (en) 1982-07-29
SU1176837A3 (ru) 1985-08-30
DE3146867A1 (de) 1982-07-08
FR2495615B1 (fr) 1984-09-14

Similar Documents

Publication Publication Date Title
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
FR2504931B1 (fr) Ionomeres modifies, leur preparation et leur utilisation
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE896993A (fr) FACTEURS 1,2,3,4 et 5 DE TEICHOMYCINE A2, LEUR PREPARATION ET LEUR UTILISATION
FR2494689B1 (fr) Xanthates, leur preparation et leur utilisation
BE896018A (fr) Amides pyrrolacetiques, leur preparation et leur utilisation
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
BE886677A (fr) Pentapeptides homologues d'enkephaline, leur preparation et leur utilisation therapeutique
BE886676A (fr) Pentapeptides homologues d'enkephalines, leur preparation et leur utilisation therapeutique
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE877263A (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
BE891393A (fr) Esthers d'hydroxymethylpyrazines substituees leur preparation et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
BE888608A (fr) Esters de steroide-oxazoles, leur preparation et leur utilisation,

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.R.L.

Effective date: 19911231